Cargando…
Pathways regulating the expression of the immunomodulatory protein glycodelin in non-small cell lung cancer
Glycodelin [gene name, progesterone associated endometrial protein (PAEP)] was initially described as an immune system modulator in reproduction. Today, it is also known to be expressed in several types of cancer, including non-small cell lung cancer (NSCLC). In this cancer type, the feasibility of...
Autores principales: | Weber, Rebecca, Meister, Michael, Muley, Thomas, Thomas, Michael, Sültmann, Holger, Warth, Arne, Winter, Hauke, Herth, Felix J.F., Schneider, Marc A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317686/ https://www.ncbi.nlm.nih.gov/pubmed/30535430 http://dx.doi.org/10.3892/ijo.2018.4654 |
Ejemplares similares
-
Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma
por: Schneider, Marc A., et al.
Publicado: (2016) -
Glycodelin as a Serum and Tissue Biomarker for Metastatic and Advanced NSCLC
por: Schneider, Marc A., et al.
Publicado: (2018) -
AURKA, DLGAP5, TPX2, KIF11 and CKAP5: Five specific mitosis-associated genes correlate with poor prognosis for non-small cell lung cancer patients
por: Schneider, Marc A., et al.
Publicado: (2017) -
FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC
por: Richtmann, Sarah, et al.
Publicado: (2019) -
Molecular signatures in IASLC/ATS/ERS classified growth patterns of lung adenocarcinoma
por: Zabeck, Heike, et al.
Publicado: (2018)